# A Clinical Trial Assessing the Efficacy of Intravenous Iron for the Treatment of Anemia Following Cardiac Surgery

> **NCT04608539** · PHASE4 · COMPLETED · sponsor: **Michael Kremke** · enrollment: 110 (actual)

## Conditions studied

- Anemia Postoperative

## Interventions

- **DRUG:** Ferric Derisomaltose
- **DRUG:** Ferrous sulfate
- **DRUG:** normal saline

## Key facts

- **NCT ID:** NCT04608539
- **Lead sponsor:** Michael Kremke
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-21
- **Primary completion:** 2023-06-27
- **Final completion:** 2023-06-27
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2023-06-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04608539

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04608539, "A Clinical Trial Assessing the Efficacy of Intravenous Iron for the Treatment of Anemia Following Cardiac Surgery". Retrieved via AI Analytics 2026-09-24 from https://api.ai-analytics.org/clinical/NCT04608539. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*